Agenus Inc (AGEN)

NASDAQ HEALTHCARE
$3.90 +3.72% RSI 48 Neutral Add Alert

Moving Averages

SMA 200
$4.12
Price below

Company Profile

Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company is headquartered in Lexington, Massachusetts.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$152.06M
Beta
1.607
Dividend Yield
0.00%
52-Week High
$7.34
52-Week Low
$1.6

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 57.0
VRTX
Vertex Pharmaceuticals Inc
RSI 41.0
CRSP
CRISPR Therapeutics AG
RSI 50.0
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 50.0
MRNA
Moderna Inc
RSI 36.0
VKTX
Viking Therapeutics Inc
RSI 38.0

Data last updated: April 11, 2026 at 5:19 PM EDT

Track AGEN for free

Get e-mail RSI alerts when Agenus Inc enters oversold or overbought territory. Free forever.

Add Alert